Literature DB >> 2763953

Soft-tissue masses: diagnosis using MR imaging.

M J Kransdorf1, J S Jelinek, R P Moser, J A Utz, A C Brower, T M Hudson, B H Berrey.   

Abstract

The MR images of 112 soft-tissue masses of various causes were retrospectively reviewed. Pathologic diagnosis by biopsy was available in 96 cases. Diagnosis in the remaining 16 cases was established by characteristic radiographs, CT scans, and/or arteriograms, in conjunction with appropriate history and clinical follow-up. All masses were evaluated with both T1-weighted, 300-600/20-30 (TR/TE), and T2-weighted, 2000/80-100, images. They were reviewed to determine (1) if these images were sufficiently unique to allow a preoperative diagnosis based exclusively on the MR appearance and (2) if benignity vs malignancy could be predicted on the basis of the analysis of the MR image characteristics of the lesion. Concerning the latter, attention was directed to the margins of the lesions, to the impact of the lesion on the surrounding tissues (edema, infiltration, etc.), and to the intensity and homogeneity of the MR signal of the lesion. MR images were sufficiently characteristic to allow a specific diagnosis in 27 (24%) of the 112 cases (10 lipomas, eight hemangiomas, six pigmented villonodular synovitis, two hematomas, and one arteriovenous malformation). MR was incapable of reliably distinguishing between benign and malignant soft-tissue tumors.

Entities:  

Mesh:

Year:  1989        PMID: 2763953     DOI: 10.2214/ajr.153.3.541

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  54 in total

1.  Accuracy of MRI in characterization of soft tissue tumors and tumor-like lesions. A prospective study in 548 patients.

Authors:  Jan L M A Gielen; Arthur M De Schepper; Filip Vanhoenacker; Paul M Parizel; Xiaoling L Wang; Raf Sciot; Joost Weyler
Journal:  Eur Radiol       Date:  2004-07-29       Impact factor: 5.315

2.  Case report 751: Spindle cell lipoma causing marked bone erosion.

Authors:  I J Braunschweig; I H Stein; M I Dodwad; A F Rangwala; A Lopano
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

Review 3.  Magnetic resonance imaging in rheumatology.

Authors:  C W Heron
Journal:  Ann Rheum Dis       Date:  1992-12       Impact factor: 19.103

4.  Magnetic resonance imaging of peripheral soft tissue hemangiomas.

Authors:  M C Nelson; M A Stull; G P Teitelbaum; R H Patt; E E Lack; G P Bogumill; M T Freedman
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

5.  MR imaging of calcifying aponeurotic fibroma of the thigh.

Authors:  Hyo-Sung Kwak; Sang-Yong Lee; Jung-Ryul Kim; Kwang-Bok Lee
Journal:  Pediatr Radiol       Date:  2003-12-20

Review 6.  Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques.

Authors:  Laura M Fayad; Michael A Jacobs; Xin Wang; John A Carrino; David A Bluemke
Journal:  Radiology       Date:  2012-11       Impact factor: 11.105

7.  Pigmented villonodular synovitis: MRI characteristics.

Authors:  T H Hughes; D J Sartoris; M E Schweitzer; D L Resnick
Journal:  Skeletal Radiol       Date:  1995-01       Impact factor: 2.199

8.  Intra-articular synovial sarcoma.

Authors:  Michael V Friedman; Michael Kyriakos; Matthew J Matava; Douglas J McDonald; Jack W Jennings; Daniel E Wessell
Journal:  Skeletal Radiol       Date:  2013-03-01       Impact factor: 2.199

9.  Imaging strategies in the evaluation of soft-tissue hemangiomas of the extremities: correlation of the findings of plain radiography, angiography, CT, MRI, and ultrasonography in 12 histologically proven cases.

Authors:  A Greenspan; J P McGahan; P Vogelsang; R M Szabo
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

10.  Epitrochlear cat scratch disease: unique imaging features allowing differentiation from other soft tissue masses of the medial arm.

Authors:  Stephanie A Bernard; Eric A Walker; John F Carroll; Mary Klassen-Fischer; Mark D Murphey
Journal:  Skeletal Radiol       Date:  2016-05-18       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.